NO2999707T3 - - Google Patents

Info

Publication number
NO2999707T3
NO2999707T3 NO14725726A NO14725726A NO2999707T3 NO 2999707 T3 NO2999707 T3 NO 2999707T3 NO 14725726 A NO14725726 A NO 14725726A NO 14725726 A NO14725726 A NO 14725726A NO 2999707 T3 NO2999707 T3 NO 2999707T3
Authority
NO
Norway
Application number
NO14725726A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48463869&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2999707(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2999707T3 publication Critical patent/NO2999707T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO14725726A 2013-05-23 2014-05-23 NO2999707T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13169009 2013-05-23
PCT/EP2014/060665 WO2014187957A1 (en) 2013-05-23 2014-05-23 Tylosin derivatives and method for preparation thereof
EP14725726.5A EP2999707B1 (en) 2013-05-23 2014-05-23 Tylosin derivatives and method for preparation thereof

Publications (1)

Publication Number Publication Date
NO2999707T3 true NO2999707T3 (cg-RX-API-DMAC10.html) 2018-08-25

Family

ID=48463869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14725726A NO2999707T3 (cg-RX-API-DMAC10.html) 2013-05-23 2014-05-23

Country Status (25)

Country Link
US (1) US9771389B2 (cg-RX-API-DMAC10.html)
EP (1) EP2999707B1 (cg-RX-API-DMAC10.html)
JP (1) JP6494600B2 (cg-RX-API-DMAC10.html)
KR (1) KR102307218B1 (cg-RX-API-DMAC10.html)
CN (1) CN105408340B (cg-RX-API-DMAC10.html)
AU (1) AU2014270353B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015029260A2 (cg-RX-API-DMAC10.html)
CA (1) CA2913098C (cg-RX-API-DMAC10.html)
CL (1) CL2015003433A1 (cg-RX-API-DMAC10.html)
DK (1) DK2999707T3 (cg-RX-API-DMAC10.html)
ES (1) ES2669615T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20180877T1 (cg-RX-API-DMAC10.html)
HU (1) HUE037868T2 (cg-RX-API-DMAC10.html)
IL (1) IL242543B (cg-RX-API-DMAC10.html)
MX (1) MX361808B (cg-RX-API-DMAC10.html)
MY (1) MY184630A (cg-RX-API-DMAC10.html)
NO (1) NO2999707T3 (cg-RX-API-DMAC10.html)
PE (1) PE20160207A1 (cg-RX-API-DMAC10.html)
PL (1) PL2999707T3 (cg-RX-API-DMAC10.html)
PT (1) PT2999707T (cg-RX-API-DMAC10.html)
RU (1) RU2714482C2 (cg-RX-API-DMAC10.html)
SI (1) SI2999707T1 (cg-RX-API-DMAC10.html)
TR (1) TR201809189T4 (cg-RX-API-DMAC10.html)
UA (1) UA117751C2 (cg-RX-API-DMAC10.html)
WO (1) WO2014187957A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物,以及包括其的组合物和方法
CN110590885A (zh) * 2019-09-30 2019-12-20 郑州大学 20-取代-5-o-碳霉胺糖基-泰乐内酯衍生物
EP4255445B1 (en) * 2020-12-03 2025-05-14 Intervet International B.V. Tildipirosin for the treatment of foot rot
CN112898361A (zh) * 2021-02-01 2021-06-04 郑州大学 5-o-碳霉胺糖基泰乐内酯衍生物及其制备方法及应用
WO2023230702A1 (en) * 2022-06-03 2023-12-07 University Of Manitoba Novel antimicrobial compounds isolated using a machine learning model trained on a high-throughput antibacterial screen

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561147B2 (en) * 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
ZA841277B (en) * 1983-02-28 1985-09-25 Lilly Co Eli C-20-and c-23-modified macrolide derivatives
IL71032A0 (en) 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
JPS59186996A (ja) * 1983-04-05 1984-10-23 Microbial Chem Res Found 20−デオキシ−20−置換アミノ−マイカミノシルレロノライド
US4921947A (en) 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
EP0262903A3 (en) * 1986-09-29 1988-11-02 Eli Lilly And Company New acyl derivatives of 20-modified tylosin and desmycosin compounds
TW226373B (cg-RX-API-DMAC10.html) * 1992-07-15 1994-07-11 Pfizer
ZA939428B (en) 1992-12-21 1995-06-15 Lilly Co Eli Therapeutic for gram-positive diseases of aquatic species
AU3121095A (en) 1994-09-22 1996-04-09 Pfizer Inc. Antibiotic macrolides
ES2213597T3 (es) * 1999-08-30 2004-09-01 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Antibioticos macrolidos y tratamiento de la pasteurelosis.
US6506885B1 (en) * 2001-09-27 2003-01-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
US6576615B2 (en) 2001-11-08 2003-06-10 Enanta Pharmaceuticals, Inc. 4′-O-substituted tylosin analogs
US6664240B2 (en) 2001-11-15 2003-12-16 Enanta Pharmaceuticals, Inc. Tylosin derivatives having antibacterial activity
US6753415B2 (en) 2002-04-19 2004-06-22 Enanta Pharmaceuticals, Inc. 23-O-substituted 5-O-mycaminosyltylonide derivatives
US6710034B2 (en) 2002-04-19 2004-03-23 Enanta Pharmaceuticals, Inc. 5-O-mycaminosyltylonide derivatives
WO2005118610A2 (en) 2004-06-01 2005-12-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US7247617B2 (en) * 2004-07-13 2007-07-24 Kosan Biosciences Incorporated Sixteen-member macrolide antiinfective agents
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
DE102005061326A1 (de) 2005-12-20 2007-06-21 Basell Polyolefine Gmbh Verfahren zur Herstellung von Metallocenen aus recycelten, substituierten Cyclopentadienylderivaten
JP5323696B2 (ja) * 2006-07-28 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー マクロライド合成方法
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
US20090131343A1 (en) 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
US20110071096A1 (en) * 2009-09-23 2011-03-24 Idexx Laboratories, Inc. Macrolides Having Antibiotic Activity
JP6170064B2 (ja) * 2011-11-25 2017-07-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 抗菌性チロシン誘導体およびその製造方法

Also Published As

Publication number Publication date
CN105408340B (zh) 2020-06-12
ES2669615T3 (es) 2018-05-28
UA117751C2 (uk) 2018-09-25
JP2016519153A (ja) 2016-06-30
HUE037868T2 (hu) 2018-09-28
AU2014270353A1 (en) 2015-11-26
MX361808B (es) 2018-12-14
PL2999707T3 (pl) 2018-09-28
US9771389B2 (en) 2017-09-26
CL2015003433A1 (es) 2016-07-15
KR20160014656A (ko) 2016-02-11
CA2913098A1 (en) 2014-11-27
US20160108077A1 (en) 2016-04-21
RU2015155032A (ru) 2017-06-27
CN105408340A (zh) 2016-03-16
WO2014187957A1 (en) 2014-11-27
EP2999707B1 (en) 2018-03-28
HK1216753A1 (zh) 2016-12-02
BR112015029260A2 (pt) 2017-07-25
PE20160207A1 (es) 2016-05-22
EP2999707A1 (en) 2016-03-30
SI2999707T1 (en) 2018-07-31
KR102307218B1 (ko) 2021-10-05
DK2999707T3 (en) 2018-06-06
AU2014270353B2 (en) 2018-09-20
PT2999707T (pt) 2018-05-23
JP6494600B2 (ja) 2019-04-03
NZ714071A (en) 2020-12-18
MX2015016118A (es) 2016-06-21
IL242543B (en) 2020-10-29
RU2714482C2 (ru) 2020-02-18
RU2015155032A3 (cg-RX-API-DMAC10.html) 2018-04-28
TR201809189T4 (tr) 2018-07-23
CA2913098C (en) 2021-11-02
MY184630A (en) 2021-04-11
HRP20180877T1 (hr) 2018-07-13

Similar Documents

Publication Publication Date Title
AP2016009275A0 (cg-RX-API-DMAC10.html)
BR112015007533A2 (cg-RX-API-DMAC10.html)
BR102016010778A2 (cg-RX-API-DMAC10.html)
BR112014017733A2 (cg-RX-API-DMAC10.html)
BR112014018502A2 (cg-RX-API-DMAC10.html)
BR112014017739A2 (cg-RX-API-DMAC10.html)
BR112014019326A2 (cg-RX-API-DMAC10.html)
BR112014020341A2 (cg-RX-API-DMAC10.html)
BR112014017765A2 (cg-RX-API-DMAC10.html)
BR112014017669A2 (cg-RX-API-DMAC10.html)
BR112014021878A2 (cg-RX-API-DMAC10.html)
BR112014019204A2 (cg-RX-API-DMAC10.html)
BR112015015948A2 (cg-RX-API-DMAC10.html)
BR112014017722A2 (cg-RX-API-DMAC10.html)
BR112014017653A2 (cg-RX-API-DMAC10.html)
BR112014018578A2 (cg-RX-API-DMAC10.html)
BR112014017601A2 (cg-RX-API-DMAC10.html)
BR112015015312A2 (cg-RX-API-DMAC10.html)
BR112014024039A2 (cg-RX-API-DMAC10.html)
BR112014018496A2 (cg-RX-API-DMAC10.html)
BR112014017745A2 (cg-RX-API-DMAC10.html)
BR112014018514A2 (cg-RX-API-DMAC10.html)
BR112016015341A2 (cg-RX-API-DMAC10.html)
BR112014018484A2 (cg-RX-API-DMAC10.html)
BR112015011379A2 (cg-RX-API-DMAC10.html)